Home » Advanced Materials » India Biomaterials Market

India Biomaterials Market

India Biomaterials Market Based on Product Type (Metallic: Stainless Steel, Gold, Magnesium, Silver, Others; Ceramic: Aluminum Oxide, Calcium Sulfate, Carbon, Glass, Others; Polymer: Polymethylmethacrylate, Polyethylene, Polyester, Nylon, Others; Natural: Hyaluronic Acid, Collagen, Gelatin, Fibrin, and Others; Others); Based on Application (Cardiovascular, Orthopedics, Plastic Surgery, Ophthalmology, Dental, Neurology, Tissue Engineering, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
India Biomaterials Market Size 2024	USD 5,742.44 million
India Biomaterials Market, CAGR	17.23%
India Biomaterials Market Size 2032	USD 20,490.05 million

Market Overview

India Biomaterials market size was valued at USD 5,742.44 million in 2024 and is anticipated to reach USD 20,490.05 million by 2032, at a CAGR of 17.23% during the forecast period (2024-2032).

The India biomaterials market is driven by increasing demand for advanced healthcare solutions, particularly in the fields of orthopedics, dental care, and tissue engineering. Rising incidences of chronic diseases, coupled with an aging population, are fueling the need for biocompatible materials in implants and prosthetics. Additionally, government initiatives promoting medical device innovation and healthcare infrastructure are enhancing market growth. The shift towards personalized medicine and the growing awareness of the benefits of biomaterials further support market expansion. Technological advancements in biomaterials, including the development of biodegradable, bioactive, and multifunctional materials, are also driving innovation. The trend towards sustainable, eco-friendly biomaterials, coupled with increasing research in regenerative medicine, is expected to shape the future of the industry. As a result, the market is poised for rapid growth, driven by both healthcare demand and cutting-edge material science advancements.

The geographical landscape of the India biomaterials market reveals strong growth potential across all major regions, with Northern and Western India emerging as key hubs due to their advanced healthcare infrastructure and presence of major research institutions. Southern India also plays a vital role, particularly in biomedical innovation and the adoption of regenerative medicine technologies. Meanwhile, the Eastern region is steadily expanding, supported by improving healthcare access and government initiatives. Key players driving the market include Orthogen, Biomet, Medicure, CureMetrix, and Ethan Group, each contributing through a diverse range of biomaterial products and strategic investments in R&D. These companies are actively involved in expanding their product portfolios, enhancing production capabilities, and forging partnerships to meet the rising demand for biomaterials in applications such as orthopedics, cardiovascular devices, and dental implants. As technological advancements continue to reshape the sector, both domestic and international players are expected to deepen their footprint in the Indian biomaterials industry.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The India biomaterials market was valued at USD 5,742.44 million in 2024 and is projected to reach USD 20,490.05 million by 2032, growing at a CAGR of 17.23%.

The global biomaterials market was valued at USD 2,03,827.80 million in 2024 and is projected to reach USD 6,19,828.57 million by 2032, growing at a CAGR of 14.91% during the forecast period.

Increasing demand for advanced implants and prosthetics due to a rise in chronic diseases and aging population is driving market growth.
Emerging trends include the use of biodegradable, smart, and customizable biomaterials, especially in regenerative medicine and 3D printing.
Major players such as Orthogen, Biomet, and Medicure are expanding product portfolios and focusing on R&D to stay competitive.
Regulatory challenges and high costs of advanced biomaterials continue to restrain market growth in certain regions.
Northern and Western regions lead market growth due to better healthcare infrastructure and innovation hubs, while Eastern India shows emerging potential.
The market is becoming increasingly innovation-driven, with partnerships between medical institutions and technology firms boosting development.

Report Scope

This report segments the India Biomaterials Market as follows:

Market Drivers

Increasing Healthcare Demands and Aging Population

The growing healthcare demands in India, coupled with a rapidly aging population, are significant drivers for the biomaterials market. India has witnessed a rise in chronic diseases such as cardiovascular disorders, diabetes, and joint-related issues, leading to an increased need for medical devices and implants. The aging population, which is expected to account for a larger share of the total population in the coming years, further intensifies the need for biomaterials in prosthetics, orthopedic implants, and dental devices. Biomaterials, due to their compatibility with the human body, are becoming essential for improving the quality of life for the elderly, driving market growth. As the prevalence of age-related diseases rises, the demand for durable, biocompatible, and functional materials in healthcare applications will continue to escalate.

Technological Advancements in Biomaterials

Technological innovations play a crucial role in driving the growth of the India biomaterials market. For instance, the National Biotechnology Development Strategy outlines India’s focus on advancing biomaterials through research in biodegradable polymers, bioactive ceramics, and composites. Researchers are focusing on the development of advanced biomaterials that offer enhanced performance, biocompatibility, and functional properties. For instance, the development of tissue engineering materials and scaffold-based biomaterials is paving the way for regenerative medicine applications, where damaged tissues can be replaced or repaired. The ongoing research into personalized biomaterials, which are tailored to the specific needs of individuals, further adds to the market’s potential. These advancements enable manufacturers to produce highly effective and patient-specific biomaterials, which in turn fuels market demand.

Government Initiatives and Healthcare Infrastructure Development

Government initiatives and investments in the healthcare sector have also been a driving factor for the biomaterials market in India. For instance, the BIRAC Biomanufacturing Initiative supports biomaterials research and commercialization, fostering innovation in medical applications.The Indian government has launched various programs to improve healthcare accessibility and affordability, such as the National Health Protection Scheme (Ayushman Bharat), which aims to provide health coverage to millions of low-income families. These initiatives have stimulated demand for affordable yet advanced medical devices, including those utilizing biomaterials. Additionally, the increasing focus on the development of healthcare infrastructure and medical tourism in India has created opportunities for the biomaterials market. As hospitals and medical facilities invest in cutting-edge technologies, the need for biomaterials in implants, prosthetics, and medical devices becomes critical. The expanding healthcare sector is expected to continue driving the demand for biomaterials as a result of these initiatives.

Growing Focus on Sustainability and Eco-friendly Solutions

Sustainability concerns are becoming a growing trend in the biomaterials market, further propelling the industry’s growth. As environmental awareness increases globally, there is a push towards developing biodegradable and eco-friendly biomaterials. In India, there is an increasing emphasis on sustainability within the healthcare sector, with both government and private players focusing on reducing environmental footprints. The demand for biocompatible, eco-friendly biomaterials, such as plant-based polymers and recycled materials, is expected to rise in response to this trend. Furthermore, eco-friendly biomaterials reduce the risk of long-term environmental contamination, which is critical in medical waste management. The rise in consumer preference for sustainable products, combined with advancements in biodegradable biomaterial technologies, is expected to significantly influence the market’s trajectory over the next decade.

Market Trends

Shift Toward Biodegradable and Sustainable Biomaterials

One of the key trends in the India biomaterials market is the growing focus on biodegradable and sustainable biomaterials. For instance, the Green Bharat Biomanufacturing Initiative promotes the development of biodegradable polymers to reduce environmental impact. With increasing environmental concerns, both consumers and manufacturers are turning toward eco-friendly alternatives to traditional synthetic biomaterials. Materials such as biodegradable polymers, bioactive ceramics, and natural-based polymers are gaining popularity due to their reduced environmental impact. This shift is driven by advancements in material science, which have made these alternatives more viable for medical applications. As the Indian healthcare sector increasingly adopts sustainable practices, the demand for biodegradable and recyclable biomaterials is expected to rise significantly, aligning with global sustainability trends.

Advancements in 3D Printing and Customizable Biomaterials

The integration of 3D printing technology in the biomaterials sector is revolutionizing the development of customized medical solutions. In India, the use of 3D printing in healthcare is becoming more widespread, enabling the production of patient-specific implants, prosthetics, and surgical models. This trend is enhancing the precision and effectiveness of medical treatments, as 3D printing allows for the creation of biomaterials tailored to the individual’s anatomical needs. Moreover, advancements in the materials used for 3D printing, such as bioinks and biocompatible filaments, are further driving this trend. Customizable biomaterials are increasingly being used in orthopedic, dental, and tissue engineering applications, making treatments more personalized and improving patient outcomes.

Integration of Biomaterials in Regenerative Medicine

Regenerative medicine is another growing trend in the Indian biomaterials market, with significant attention being given to the development of biomaterials for tissue engineering and cell therapy. For instance, India’s biomaterials healthcare market is witnessing increased investment in regenerative medicine applications, including stem cell therapies and tissue regeneration. In India, ongoing research into stem cell therapies and tissue regeneration is leading to the creation of specialized biomaterials that can promote tissue healing, reduce rejection, and improve recovery times. This trend is particularly relevant for treating conditions such as burns, spinal cord injuries, and organ failures. As the understanding of regenerative processes expands, biomaterials will play an increasingly vital role in improving the effectiveness of regenerative therapies.

Growing Adoption of Smart Biomaterials in Healthcare

Smart biomaterials, which respond to environmental stimuli such as temperature, pH, or pressure, are increasingly being integrated into medical devices and implants. These materials are capable of changing their properties or releasing drugs in response to specific biological conditions, offering potential benefits for controlled drug delivery systems and personalized treatments. In India, the adoption of smart biomaterials is growing, particularly in applications like wound healing, drug delivery, and implantable devices. As the healthcare industry seeks more precise, efficient, and patient-centric solutions, the demand for smart biomaterials is expected to increase. This trend reflects the broader movement towards more sophisticated, functional, and adaptive materials that can better meet the needs of modern healthcare.

Market Challenges Analysis

Regulatory and Approval Complexities

One of the key challenges facing the India biomaterials market is the complex and time-consuming regulatory approval process for new materials and medical devices. For instance, the Central Drugs Standard Control Organization (CDSCO) has stringent guidelines requiring extensive testing for safety, efficacy, and biocompatibility before biomaterials can be approved. The approval process for medical devices and biomaterials involves rigorous testing for safety, efficacy, and biocompatibility, which can delay product launches and increase costs. Additionally, the lack of a streamlined regulatory framework for emerging biomaterials, such as those used in tissue engineering or regenerative medicine, further complicates the market entry for new technologies. These regulatory delays and the complexity of navigating different requirements across states can limit the growth potential of the market and discourage innovation.

High Costs and Limited Access to Advanced Technologies

Another significant challenge is the high cost associated with advanced biomaterials and limited access to cutting-edge technologies in India. Many high-quality biomaterials, such as bioactive ceramics and biodegradable polymers, are imported, which increases their cost, making them less accessible to a broader segment of the healthcare market, especially in rural areas. Additionally, the adoption of advanced manufacturing techniques, such as 3D printing and smart biomaterials, requires substantial investment in infrastructure and skilled labor. While larger urban centers may have access to these technologies, the lack of widespread availability in smaller cities and rural regions can limit the overall adoption of biomaterials across the country. This disparity in access to both advanced materials and technologies presents a barrier to the growth of the biomaterials sector, especially as the market seeks to cater to the entire population’s healthcare needs.

Market Opportunities

The India biomaterials market presents significant opportunities driven by increasing healthcare needs and technological advancements. With a rapidly growing population, rising incidences of chronic diseases, and an aging demographic, there is a heightened demand for medical devices and implants that utilize advanced biomaterials. The orthopedic and dental sectors, in particular, are poised for expansion as more individuals seek treatments for joint replacements, dental implants, and tissue engineering applications. Additionally, the Indian government’s initiatives to improve healthcare access and affordability, such as Ayushman Bharat, further stimulate the demand for cost-effective yet advanced biomaterial solutions. These factors provide manufacturers with the opportunity to invest in research and development of affordable, high-performance biomaterials to meet the diverse healthcare needs of the country.

The increasing adoption of cutting-edge technologies such as 3D printing and regenerative medicine presents a substantial opportunity for the biomaterials sector. As 3D printing enables the production of customized implants and prosthetics tailored to individual patients, the demand for specialized biomaterials is expected to rise. Similarly, the growing focus on regenerative medicine offers opportunities for developing biomaterials that support tissue repair, stem cell therapy, and wound healing. With advancements in smart biomaterials, which respond to environmental stimuli for controlled drug delivery and tissue growth, India stands to benefit from innovations that improve patient outcomes and healthcare efficiency. By capitalizing on these technological trends, the biomaterials market in India can continue to grow and attract investments, making it an increasingly vital component of the nation’s healthcare industry.

Market Segmentation Analysis:

By Product Type:

The India biomaterials market is segmented by product type into metallic, ceramic, polymer, natural, and other materials. Metallic biomaterials, including stainless steel, gold, magnesium, silver, and others, dominate due to their widespread use in orthopedic implants, cardiovascular devices, and dental applications. Stainless steel is particularly common in the manufacturing of joint replacements, as it offers durability and corrosion resistance. Ceramic biomaterials, such as aluminum oxide, calcium sulfate, carbon, glass, and others, are increasingly utilized in applications that require wear resistance and biocompatibility. These materials are often found in dental implants and joint prosthetics. Polymer-based biomaterials including polymethylmethacrylate, polyethylene, polyester, and nylon are commonly used in applications like tissue engineering, wound healing, and drug delivery systems due to their flexibility, ease of fabrication, and cost-effectiveness. Natural biomaterials like hyaluronic acid, collagen, gelatin, and fibrin are gaining popularity, particularly in regenerative medicine and wound healing due to their biocompatibility and ability to support tissue regeneration. The “Others” category includes emerging materials like smart biomaterials and biodegradable polymers, which are driving innovation in the sector.

By Application:

The biomaterials market in India is also segmented by application, with significant demand arising in cardiovascular, orthopedic, plastic surgery, ophthalmology, dental, neurology, tissue engineering, and other medical fields. Cardiovascular applications are particularly prominent due to the rising prevalence of heart disease, with biomaterials being used in stents, pacemakers, and heart valve replacements. The orthopedic segment is another major driver, fueled by the increasing need for joint replacement surgeries and bone healing. Plastic surgery and ophthalmology also present strong growth opportunities, with biomaterials being used for facial reconstruction, eye implants, and corneal treatments. Dental applications are a key segment due to the high demand for dental implants and prosthetics in India, driven by an increasing focus on oral health. The neurology and tissue engineering segments are witnessing innovation, with the development of biomaterials designed for nerve regeneration and tissue scaffolding. As technology continues to advance, biomaterials are expected to play an even larger role in regenerative medicine and specialized treatments, offering significant growth potential in various healthcare sectors.

Segments:

Based on Product Type:

Metallic
Stainless Steel
Gold
Magnesium
Silver
Others
Ceramic
Aluminum Oxide
Calcium Sulfate
Carbon
Glass
Others
Polymer
Polymethylmethacrylate
Polyethylene
Polyester
Nylon
Others
Natural
Hyaluronic Acid
Collagen
Gelatin
Fibrin and others
Others

Based on Application:

Cardiovascular
Orthopedics
Plastic Surgery
Ophthalmology
Dental
Neurology
Tissue Engineering
Others

Based on the Geography:

Northern
Western
Southern
Eastern

Regional Analysis

Northern region

The Northern region of India holds the largest share in the country’s biomaterials market, accounting for approximately 35% of the total market revenue. This dominance is primarily attributed to the presence of major metropolitan cities such as Delhi, Chandigarh, and Lucknow, which are home to several advanced healthcare institutions and research centers. The region has seen significant investments in public and private healthcare infrastructure, promoting the adoption of advanced medical technologies including biomaterials in orthopedic, cardiovascular, and dental applications. Additionally, the presence of leading medical colleges and hospitals supports ongoing clinical research and trials, fostering innovation in biomaterial usage. With growing patient awareness, improved healthcare accessibility, and the expansion of tertiary care facilities, the Northern region continues to be a key driver of growth in the biomaterials sector.

Western region

The Western region of India commands a substantial 28% share of the biomaterials market. This region includes economically progressive states such as Maharashtra and Gujarat, which have well-established medical device manufacturing hubs and biotechnology parks. Mumbai and Pune, in particular, are leading centers for medical research and hospital networks, encouraging the use of high-performance biomaterials in plastic surgery, dental care, and orthopedic implants. Gujarat’s focus on pharmaceutical and medical device innovation also contributes to the region’s market strength. Favorable government policies, availability of skilled labor, and increasing investments in healthcare startups are further boosting the biomaterials market in the Western region. This area is also benefiting from the growth of medical tourism, especially in cosmetic and dental procedures that rely heavily on advanced biomaterials.

Southern region

In the Southern region, which holds around 22% of the market share, growth is driven by the presence of some of India’s most reputed hospitals and academic institutions in cities like Bengaluru, Chennai, and Hyderabad. These cities serve as major hubs for biomedical research and innovation. The Southern region has demonstrated high adoption rates for technologies such as 3D printing and regenerative medicine, increasing the use of customized and bioengineered materials. Moreover, the strong IT and biotech sectors in this region facilitate collaboration between material science and healthcare, enhancing the development of smart biomaterials. Rising healthcare expenditure, patient awareness, and a steady influx of medical tourists are further propelling demand for biomaterials in this part of the country.

Eastern region

The Eastern region, though currently accounting for a smaller market share of about 15%, is witnessing steady growth in the biomaterials market. The expansion of healthcare infrastructure in states like West Bengal, Odisha, and Assam is gradually improving access to advanced medical treatments. Kolkata, as a healthcare center in the region, is seeing increased demand for biomaterial-based implants and devices, especially in dental and orthopedic applications. Government-led health schemes and public-private partnerships are helping bridge the gap in healthcare accessibility, which in turn is encouraging the use of cost-effective biomaterials. While the market is relatively nascent compared to other regions, increasing investments in healthcare and research, along with rising patient awareness, indicate strong growth potential for the Eastern biomaterials market in the coming years.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Orthogen
Biomet
Medicure
CureMetrix
Ethan Group

Competitive Analysis

The competitive landscape of the India biomaterials market is marked by innovation, strategic expansion, and increasing investment in research and development. Leading players such as Orthogen, Biomet, Medicure, CureMetrix, and Ethan Group are actively shaping the industry through diverse product offerings, advanced biomaterial technologies, and targeted market strategies. These companies are focusing on the development of biocompatible, cost-effective materials for applications in orthopedics, dental care, cardiovascular devices, and regenerative medicine. Strategic collaborations with hospitals, research institutions, and technology providers are also a key focus, helping players to enhance product efficacy and market reach. Many of these companies are investing in smart and biodegradable biomaterials to meet the growing demand for sustainable and patient-centric healthcare solutions. Moreover, domestic firms are leveraging government support and Make in India initiatives to boost local manufacturing capabilities, reducing dependence on imports. This competitive environment encourages continuous innovation, positioning India as an emerging hub for biomaterials innovation and manufacturing.

Recent Developments

In April 2025, BASF expanded its EcoBalanced portfolio for Care Chemicals in North America, introducing the first EcoBalanced personal care products in the region. These include Dehyton® PK 45 and Dehyton® KE UP, both certified as EcoBalanced grades using a biomass balance (BMB) approach to reduce carbon footprint. Additionally, six U.S. Care Chemicals production sites are now powered entirely by renewable electricity, saving approximately 33,000 tons of CO₂ annually.
In November 2024, Covestro began production of Desmophen® CQ NH, a partially bio-based polyaspartic resin (at least 25% bio-based content), at its Foshan, China site. The facility is powered entirely by renewable energy, and the product is used in wind turbine and flooring coatings, supporting both local supply and sustainability goals.
In January 2025, BASF’s Performance Materials division transitioned all European sites to 100% renewable electricity, covering engineering plastics, polyurethanes, thermoplastic polyurethanes, and specialty polymers.
In June 2023, Invibio announced a collaboration with Paragon Medical to scale up manufacturing of PEEK-OPTIMA Ultra-Reinforced composite trauma devices in China, responding to growing global demand for high-performance biomaterials in trauma fixation.
In February 2023, Celanese introduced ECO-B, more sustainable versions of Acetyl Chain materials, incorporating mass balance bio-content to provide chemically identical, bio-based alternatives for engineered materials.

Market Concentration & Characteristics

The India biomaterials market exhibits a moderately concentrated structure, characterized by the presence of both established global players and emerging domestic manufacturers. While a few key companies dominate the market through extensive product portfolios, advanced technologies, and strong distribution networks, there is a growing number of regional players entering the space with niche innovations and cost-effective solutions. The market is marked by rapid technological advancements, high research and development activity, and a strong focus on customization and biocompatibility. Additionally, the industry demonstrates a high level of specialization, with companies focusing on specific applications such as orthopedics, dental, and cardiovascular solutions. Despite entry barriers such as regulatory compliance and high initial investment, the sector remains attractive due to increasing healthcare demands and government support. Overall, the market is dynamic and innovation-driven, with opportunities for new entrants to succeed through differentiation, strategic partnerships, and alignment with the evolving needs of the Indian healthcare ecosystem.

Report Coverage

The research report offers an in-depth analysis based on Product Type, Application and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

India will see a significant rise in demand for biomaterials driven by the expanding healthcare and medical devices sector.
Domestic production of biomaterials will grow as the government boosts support for Make in India initiatives.
Research and development in biodegradable and bioresorbable materials will gain momentum in collaboration with academic institutions.
The orthopedic and dental implant markets will continue to be key drivers of biomaterials consumption.
India will attract foreign investment in biomaterials manufacturing due to cost advantages and skilled workforce availability.
Regulatory frameworks will evolve to streamline approvals and ensure quality and safety standards.
Public-private partnerships will increase in order to accelerate innovation and commercialization of biomaterial technologies.
Start-ups and SMEs will play a growing role in introducing niche biomaterial solutions for wound healing and tissue engineering.
Export potential for Indian biomaterials will rise as global demand for affordable and quality products increases.
Integration of digital technologies and advanced manufacturing will enhance efficiency and customization in biomaterials production.

CHAPTER NO. 1 : INTRODUCTION 18

1.1.1. Report Description 18

Purpose of the Report 18

USP & Key Offerings 18

1.1.2. Key Benefits for Stakeholders 18

1.1.3. Target Audience 19

1.1.4. Report Scope 19

CHAPTER NO. 2 : EXECUTIVE SUMMARY 20

2.1. India Biomaterials Market Snapshot 20

2.1.1. India Biomaterials Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : INDIA BIOMATERIALS MARKET – INDUSTRY ANALYSIS 23

3.1. Introduction 23

3.2. Market Drivers 24

3.2.1. Emerging Trends in Regenerative Medicine and Tissue Engineering 24

3.2.2. Government Support for Research and Innovation in Healthcare 25

3.3. Market Restraints 26

3.3.1. Regulatory Challenges and Long Approval Times which is Lengthy and Complex 26

3.4. Market Opportunities 27

3.4.1. Market Opportunity Analysis 27

3.5. Porter’s Five Forces Analysis 28

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 29

4.1. Company Market Share Analysis – 2024 29

4.1.1. India Biomaterials Market: Company Market Share, by Volume, 2024 29

4.1.2. India Biomaterials Market: Company Market Share, by Revenue, 2024 30

4.1.3. India Biomaterials Market: Top 6 Company Market Share, by Revenue, 2024 30

4.1.4. India Biomaterials Market: Top 3 Company Market Share, by Revenue, 2024 31

4.2. India Biomaterials Market Company Revenue Market Share, 2024 32

4.3. Company Assessment Metrics, 2024 33

4.3.1. Stars 33

4.3.2. Emerging Leaders 33

4.3.3. Pervasive Players 33

4.3.4. Participants 33

4.4. Start-ups /SMEs Assessment Metrics, 2024 33

4.4.1. Progressive Companies 33

4.4.2. Responsive Companies 33

4.4.3. Dynamic Companies 33

4.4.4. Starting Blocks 33

4.5. Strategic Developments 34

4.5.1. Acquisitions & Mergers 34

New Product Launch 34

India Expansion 34

4.6. Key Players Product Matrix 35

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 36

5.1. PESTEL 36

5.1.1. Political Factors 36

5.1.2. Economic Factors 36

5.1.3. Social Factors 36

5.1.4. Technological Factors 36

5.1.5. Environmental Factors 36

5.1.6. Legal Factors 36

5.2. Adjacent Market Analysis 36

CHAPTER NO. 6 : INDIA BIOMATERIALS MARKET – BY PRODUCT TYPE SEGMENT ANALYSIS 37

6.1. India Biomaterials Market Overview, by Product Type Segment 37

6.1.1. India Biomaterials Market Revenue Share, By Product Type, 2023 & 2032 38

6.1.2. India Biomaterials Market Attractiveness Analysis, By Product Type 39

6.1.3. Incremental Revenue Growth Opportunity, by Product Type, 2024 – 2032 39

6.1.4. India Biomaterials Market Revenue, By Product Type, 2018, 2023, 2027 & 2032 40

6.2. Metallic 41

6.3. Stainless Steel 42

6.4. Gold 43

6.5. Magnesium 44

6.6. Silver 45

6.7. Others 46

6.8. Ceramic 47

6.9. Aluminum Oxide 48

6.10. Calcium Sulfate 49

6.11. Carbon 50

6.12. Glass 51

6.13. Others 52

6.14. Polymer 53

6.15. Polymethylmethacrylate 54

6.16. Polyethylene 55

6.17. Polyester 56

6.18. Nylon 57

6.19. Others 58

6.20. Natural 59

6.21. Hyaluronic Acid 60

6.22. Collagen 61

6.23. Gelatin 62

6.24. Fibrin 63

6.25. Others 64

6.26. Others 65

CHAPTER NO. 7 : INDIA BIOMATERIALS MARKET – BY APPLICATION SEGMENT ANALYSIS 66

7.1. India Biomaterials Market Overview, by Application Segment 66

7.1.1. India Biomaterials Market Revenue Share, By Application, 2023 & 2032 67

7.1.2. India Biomaterials Market Attractiveness Analysis, By Application 68

7.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 68

7.1.4. India Biomaterials Market Revenue, By Application, 2018, 2023, 2027 & 2032 69

7.2. Cardiovascular 70

7.3. Orthopedics 71

7.4. Plastic Surgery 72

7.5. Ophthalmology 73

7.6. Dental 74

7.7. Neurology 75

7.8. Tissue Engineering 76

7.9. Others 77

CHAPTER NO. 8 : INDIA BIOMATERIALS MARKET – INDIA ANALYSIS 78

8.1. Product Type 78

8.1.1. India Biomaterials Market Revenue, By Product Type, 2018 – 2023 (USD Million) 78

8.1.2. India Biomaterials Market Revenue, By Product Type, 2024 – 2032 (USD Million) 78

8.2. Application 79

8.2.1. India Biomaterials Market Revenue, By Application, 2018 – 2023 (USD Million) 79

8.2.2. India Biomaterials Market Revenue, By Application, 2024 – 2032 (USD Million) 79

CHAPTER NO. 9 : COMPANY PROFILES 80

9.1. Orthogen 80

9.1.1. Company Overview 80

9.1.2. Product Portfolio 80

9.1.3. Swot Analysis 80

9.1.4. Business Strategy 81

9.1.5. Financial Overview 81

9.2. Biomet 82

9.3. Medicure 82

9.4. CureMetrix 82

9.5. Ethan Group 82

9.6. Company 6 82

9.7. Company 7 82

9.8. Company 8 82

9.9. Company 9 82

9.10. Company 10 82

9.11. Company 11 82

9.12. Company 12 82

9.13. Company 13 82

9.14. Company 14 82

List of Figures

FIG NO. 1. India Biomaterials Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for India Biomaterials Market 28

FIG NO. 3. Company Share Analysis, 2024 29

FIG NO. 4. Company Share Analysis, 2024 30

FIG NO. 5. Company Share Analysis, 2024 30

FIG NO. 6. Company Share Analysis, 2024 31

FIG NO. 7. India Biomaterials Market – Company Revenue Market Share, 2024 32

FIG NO. 8. India Biomaterials Market Revenue Share, By Product Type, 2023 & 2032 38

FIG NO. 9. Market Attractiveness Analysis, By Product Type 39

FIG NO. 10. Incremental Revenue Growth Opportunity by Product Type, 2024 – 2032 39

FIG NO. 11. India Biomaterials Market Revenue, By Product Type, 2018, 2023, 2027 & 2032 40

FIG NO. 12. India Biomaterials Market for Metallic, Revenue (USD Million) 2018 – 2032 41

FIG NO. 13. India Biomaterials Market for Stainless Steel, Revenue (USD Million) 2018 – 2032 42

FIG NO. 14. India Biomaterials Market for Gold, Revenue (USD Million) 2018 – 2032 43

FIG NO. 15. India Biomaterials Market for Magnesium, Revenue (USD Million) 2018 – 2032 44

FIG NO. 16. India Biomaterials Market for Cooling Silver, Revenue (USD Million) 2018 – 2032 45

FIG NO. 17. India Biomaterials Market for Others, Revenue (USD Million) 2018 – 2032 46

FIG NO. 18. India Biomaterials Market for Ceramic, Revenue (USD Million) 2018 – 2032 47

FIG NO. 19. India Biomaterials Market for Cooling Aluminum Oxide, Revenue (USD Million) 2018 – 2032 48

FIG NO. 20. India Biomaterials Market for Calcium Sulfate, Revenue (USD Million) 2018 – 2032 49

FIG NO. 21. India Biomaterials Market for Carbon, Revenue (USD Million) 2018 – 2032 50

FIG NO. 22. India Biomaterials Market for Glass, Revenue (USD Million) 2018 – 2032 51

FIG NO. 23. India Biomaterials Market for Others, Revenue (USD Million) 2018 – 2032 52

FIG NO. 24. India Biomaterials Market for Polymer, Revenue (USD Million) 2018 – 2032 53

FIG NO. 25. India Biomaterials Market for Polymethylmethacrylate, Revenue (USD Million) 2018 – 2032 54

FIG NO. 26. India Biomaterials Market for Polyethylene, Revenue (USD Million) 2018 – 2032 55

FIG NO. 27. India Biomaterials Market for Polyester, Revenue (USD Million) 2018 – 2032 56

FIG NO. 28. India Biomaterials Market for Nylon, Revenue (USD Million) 2018 – 2032 57

FIG NO. 29. India Biomaterials Market for Others, Revenue (USD Million) 2018 – 2032 58

FIG NO. 30. India Biomaterials Market for Natural, Revenue (USD Million) 2018 – 2032 59

FIG NO. 31. India Biomaterials Market for Hyaluronic Acid, Revenue (USD Million) 2018 – 2032 60

FIG NO. 32. India Biomaterials Market for Collagen, Revenue (USD Million) 2018 – 2032 61

FIG NO. 33. India Biomaterials Market for Gelatin, Revenue (USD Million) 2018 – 2032 62

FIG NO. 34. India Biomaterials Market for Fibrin, Revenue (USD Million) 2018 – 2032 63

FIG NO. 35. India Biomaterials Market for Others, Revenue (USD Million) 2018 – 2032 64

FIG NO. 36. India Biomaterials Market for Others, Revenue (USD Million) 2018 – 2032 65

FIG NO. 37. India Biomaterials Market Revenue Share, By Application, 2023 & 2032 67

FIG NO. 38. Market Attractiveness Analysis, By Application 68

FIG NO. 39. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 68

FIG NO. 40. India Biomaterials Market Revenue, By Application, 2018, 2023, 2027 & 2032 69

FIG NO. 41. India Biomaterials Market for Cardiovascular, Revenue (USD Million) 2018 – 2032 70

FIG NO. 42. India Biomaterials Market for Orthopedics, Revenue (USD Million) 2018 – 2032 71

FIG NO. 43. India Biomaterials Market for Plastic Surgery, Revenue (USD Million) 2018 – 2032 72

FIG NO. 44. India Biomaterials Market for Ophthalmology, Revenue (USD Million) 2018 – 2032 73

FIG NO. 45. India Biomaterials Market for Dental, Revenue (USD Million) 2018 – 2032 74

FIG NO. 46. India Biomaterials Market for Neurology, Revenue (USD Million) 2018 – 2032 75

FIG NO. 47. India Biomaterials Market for Tissue Engineering, Revenue (USD Million) 2018 – 2032 76

FIG NO. 48. India Biomaterials Market for Others, Revenue (USD Million) 2018 – 2032 77

List of Tables

TABLE NO. 1. : India Biomaterials Market: Snapshot 20

TABLE NO. 2. : Drivers for the India Biomaterials Market: Impact Analysis 24

TABLE NO. 3. : Restraints for the India Biomaterials Market: Impact Analysis 26

TABLE NO. 4. : India Biomaterials Market Revenue, By Product Type, 2018 – 2023 (USD Million) 78

TABLE NO. 5. : India Biomaterials Market Revenue, By Product Type, 2024 – 2032 (USD Million) 78

TABLE NO. 6. : India Biomaterials Market Revenue, By Application, 2018 – 2023 (USD Million) 79

TABLE NO. 7. : India Biomaterials Market Revenue, By Application, 2024 – 2032 (USD Million) 79

Frequently Asked Questions

What is the current size of the India Biomaterials?

The India biomaterials market was valued at USD 5,742.44 million in 2024 and is projected to reach USD 20,490.05 million by 2032.

What factors are driving the growth of the India Biomaterials?

Growth is driven by increasing healthcare demands, rising chronic diseases, an aging population, government initiatives, and advancements in biomaterials technology.

What are the key segments within the India Biomaterials?

Key segments include metallic, ceramic, polymer, natural, and smart biomaterials, with applications in orthopedics, dental, cardiovascular, and tissue engineering.

Who are the major players in the India Biomaterials?

Major players include Orthogen, Biomet, Medicure, CureMetrix, and Ethan Group, known for innovation, R&D, and expanding biomaterial applications.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$8699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –